Invention Grant
- Patent Title: Modified nucleoside phosphoramidites
-
Application No.: US16647236Application Date: 2018-09-14
-
Publication No.: US11180524B2Publication Date: 2021-11-23
- Inventor: Sergei Gryaznov , Jin Hong , Vivek Kumar Rajwanshi , Leonid Beigelman
- Applicant: Janssen BioPharma, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Janssen BioPharma, Inc.
- Current Assignee: Janssen BioPharma, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Foley & Lardner LLP
- International Application: PCT/IB2018/057077 WO 20180914
- International Announcement: WO2019/053659 WO 20190321
- Main IPC: C07H19/10
- IPC: C07H19/10 ; C07H19/00 ; C07H19/20 ; C07H1/00

Abstract:
The present disclosure relates to compounds and compositions containing 5′-phosphoramidite nucleoside monomers of formulae (I) and (II), and methods of making and use, wherein the substituents are as defined in the appended claims.
Public/Granted literature
- US20200255468A1 MODIFIED NUCLEOSIDE PHOSPHORAMIDITES Public/Granted day:2020-08-13
Information query
IPC分类: